Institute of Biophysics, Chinese Academy of Sciences

Third Pole Environment's Radar Innovations Reveal Depth of Mount Qomolangma's Snow

Retrieved on: 
Friday, July 14, 2023
Yang Wei, Weather, STEP, Institute of Biophysics, Chinese Academy of Sciences, Radar, Climate change, GPR, Research, Sensor, Cryosphere, Snow, Surveying, Silviculture

BEIJING, July 14, 2023 /PRNewswire/ -- The researchers applied a novel approach to using ground-penetrating radar (GPR) technology, by starting measurements from exposed limestone at a lower elevation point, thus resulting in more accurate readings. Based on this new method, the scientists calculated a snow depth of 9.5 ± 1.2 meters at the summit, considerably different from previous estimates of 0.9 to 3.5 meters.

Key Points: 
  • Based on this new method, the scientists calculated a snow depth of 9.5 ± 1.2 meters at the summit, considerably different from previous estimates of 0.9 to 3.5 meters.
  • Changes in snow accumulation and drift, driven by weather variations, significantly influence total snow depth.
  • Prof. YANG Wei noted that the STEP team plans to continue leveraging this innovative radar method to study snow stratigraphy and snowpack properties on Mount Qomolangma's summit.
  • Title of original paper: Brief communication: How deep is the snow on Mount Everest?

Jiangsu continues supporting technological innovation of industries

Retrieved on: 
Friday, July 7, 2023
Chinese Academy of Engineering, People's Daily, University, Institute of Biophysics, Chinese Academy of Sciences, Research, Internet, Management, Arms industry, Engineering

The Purple Mountain Laboratories is a major sci-tech innovation platform jointly built by Jiangsu province and Nanjing in 2018.

Key Points: 
  • The Purple Mountain Laboratories is a major sci-tech innovation platform jointly built by Jiangsu province and Nanjing in 2018.
  • It gathers over 1,000 researchers and has achieved a series of world-leading results in future internet, B5G/6G communication and cyber security.
  • Recently, the facility developed a batch of core cyber technologies, including the world's first major breakthrough in wide-area deterministic network system.
  • Apart from the Purple Mountain Laboratories, Jiangsu province has built a series of other major innovation platforms such as the Suzhou Laboratory and the Taihu Laboratory of Deepsea Technological Science.

DAHON Founder Dr. David Hon: The Evolution of a Physicist to the Father of Modern Folding Bikes

Retrieved on: 
Thursday, June 8, 2023
Aircraft, Nuclear fusion, U.S. Department of Energy, Office of Inspector General, Taiwan, Gold medal, IPR, Travel, Interview, U.S. Department of Defense Strategy for Operating in Cyberspace, Gold, Education, Intellectual property, Institute of Biophysics, Chinese Academy of Sciences, Inorganic polymer, CITIC Securities, Zhejiang Xinhua Compassion Education Foundation, Beijing Stock Exchange, Research, Multimedia, Guinness, CCTV, Ministry, Student, Hughes Aircraft Company, Publication, Car, Rigidity, Gold Award, Guinness World Records, Deltec Homes, Ministry of Science, Transport, Environment, Safety, Road, Renewable energy, Fine chemical, Industrial design, Science

OLNEY, Ill., June 8, 2023 /PRNewswire/ -- Leading folding bike brand DAHON Chairman Dr. David Hon, a pioneer in the folding bicycle industry, has developed a patented technology called "Deltec" for all new DAHON bikes this year. This patented technology has been proven through extensive indoor and outdoor testing as well as riding data analyses. The Deltec technology empowers DAHON bikes with unmatched strength and speed, surpassing the performance of conventional mountain and road bikes on the market.

Key Points: 
  • The Deltec technology empowers DAHON bikes with unmatched strength and speed, surpassing the performance of conventional mountain and road bikes on the market.
  • In 1982, Dr. Hon introduced to the world the first DAHON folding bike, serving as the prototype for the majority of contemporary folding bicycles.
  • Subsequently, Dr. Hon became known as the Father of Modern Folding Bikes, transitioning from a physicist to a passionate advocate for low-carbon travel and a staunch defender of the environment.
  • No longer limited to folding bikes, DAHON's product portfolio now encompasses electric, electric assist, chauffeur, carbon fiber, telescopic, learners', and children's bikes.

An Important Step Toward International Post-Pandemic Biological Research Collaboration | CBIS 13th Biennial Meeting

Retrieved on: 
Wednesday, January 18, 2023
Disease, UCLA, Presidential Young Investigator Award, Infection, Immunity, Science, Regeneration, Communication, Institute of Biophysics, Chinese Academy of Sciences, Plant, Health, Genetics, Westlake University, Biology, Metabolism, RNA, Yale University, Systems biology, Biochemistry, Research, Cancer, Medicine, Duke University, Neuroscience, Princeton University, Pharmaceutical industry, Management

A collaboration between CBIS and Westlake University, the meeting gathered distinguished and world-renowned scientists from across all fields of life sciences under the common goal of “Enhancing and Reconnecting Biological Research in the Post-Pandemic Era”.

Key Points: 
  • A collaboration between CBIS and Westlake University, the meeting gathered distinguished and world-renowned scientists from across all fields of life sciences under the common goal of “Enhancing and Reconnecting Biological Research in the Post-Pandemic Era”.
  • The CBIS 13th Biennial Meeting facilitated an interactive platform across borders, connecting scientists and researchers to advance our fundamental understanding of biology, disease and medicine.
  • Prof. Tian Xu, chair professor of genetics and vice president of Westlake University, was one of the earliest members of CBIS.
  • With such long-lasting and meaningful connections between CBIS and Westlake University, the 13th Biennial Meeting has been a culmination of shared goals and values.

The international leading four patents of Original DHA dairy products

Retrieved on: 
Wednesday, December 7, 2022
Intellectual property, Metabolism, State Research Center for Applied Microbiology, Breeding, Fermentation, Animal husbandry, Brain, Breast milk, Patent, Milk, Dairy, Food, DHA, Cattle, GMO, Investment-specific technological progress, Chinese Academy of Fishery Sciences, Mammal, Retina, Digestion, Human, Multimedia, Microalgae, Chinese Academy of Sciences, Pesticide, SGS, R, Environment, Food safety, Animal, Absorption, Diet, Taste, Cell membrane, ISO9001, Xiamen University, Institute of Biophysics, Chinese Academy of Sciences, Fungus, Research, Ruminant, Climate, FDA, SN-2, Safety, Originality, Health, CDC, Dietary supplement, Aquaculture, Fine chemical, Science, Schizochytrium, EU

Original DHA pure milk, that is, milk comes with DHA as soon as it is squeezed out.

Key Points: 
  • Original DHA pure milk, that is, milk comes with DHA as soon as it is squeezed out.
  • Original DHA pure milk can be processed into a variety of milk products, which keep pace with conventional milk in terms of flavor, taste and physicochemical properties [2].
  • Industrialization of Original DHA Dairy Products -- Schizochytrium sp.
  • HS01) (special for cattle), our partner's Original DHA dairy products were launched in 2016, 2018 and 2020 successively.

Dao Foods Announces Investment in Six Alternative Protein Ventures

Retrieved on: 
Wednesday, April 27, 2022
Dai, Zero, Tao, Founder CEO, CEO, The Non-GMO Project, Livens Projector, Economics, Adoption, Mycelium, University of International Business and Economics (Beijing), Microalgae, University, Taste, Restaurant, Starfield, Doctor of Philosophy, GLOBE, Cell biology, Regenerative medicine, Entrepreneurship, Cohort, Technology, Food industry, CAO, Chemical engineering, Fermentation, International business, Drink, Gelatin, American Society for Cell Biology, Chinese, Institute of Biophysics, Chinese Academy of Sciences, Knowledge, Science, Aquaculture, Dietary supplement, Agriculture

SHANGHAI, April 27, 2022 (GLOBE NEWSWIRE) -- Dao Foods International today welcomes its third cohort of China-focused alternative protein ventures under its Dao Foods Incubator initiative.

Key Points: 
  • SHANGHAI, April 27, 2022 (GLOBE NEWSWIRE) -- Dao Foods International today welcomes its third cohort of China-focused alternative protein ventures under its Dao Foods Incubator initiative.
  • Dao Foods recruited these startup ventures as part of its plan, announced in 2020, to support and invest in 25-30 China-focused alternative protein ventures within three years.
  • "The alternative protein sector is still quite nascent in China," Tao Zhang, co-founder of Dao Foods, said.
  • These companies encompass fast-growing products and services, including plant-based ready-to-eat foods, plant-based dairy, plant-based protein drinks for children, herbal protein products, algae-based protein ingredients, cell-based seafood, and mycelium-based proteins.

Researchers Discover New Model for "Global" DNA Repair

Retrieved on: 
Wednesday, March 30, 2022
Cell, Face, New York University Grossman School of Medicine, NYU Langone Health, UvrABC endonuclease, NYU, State Key Laboratories, DNA, Biochemistry, Death, DNA repair, Synthetic biology, Rho, Bacteria, Alfred Noble Prize, GGR, National Natural Science Foundation of China, Pharmacology, Doctor of Philosophy, Ecology, Plant physiology, TCR, Institute of Biophysics, Chinese Academy of Sciences, RNA, National Institutes of Health, Nature Communications, Medicine, Howard Hughes Medical Institute, Genome, Programmer, Technology, National Medal of Technology and Innovation, NIH, National, Institute, Ageing, Mass spectrometry, Gene, Department, Enzyme, Exploratory Science Center, Swiss National Science Foundation, NER, Physiology, Shakne Epshtein, Vaccine, Pharmaceutical industry, Nature, Evgeny Nudler

NEW YORK, March 30, 2022 /PRNewswire/ -- Two studies provide a radically new picture of how bacterial cells continually repair damaged sections (lesions) in their DNA.

Key Points: 
  • Given that damaged DNA can result in detrimental DNA code changes (mutations) and death, cells evolved to have DNA repair machineries.
  • Widely accepted work, including studies that led to a 2015 Noble Prize , had argued that TCR played a relatively small role in repair because it relied on a putative TCR factor that made only a marginal contribution to DNA repair.
  • A parallel process, global genome repair (GGR), was assumed to scan and fix most of DNA independent of transcription.
  • Both processes were thought to set the stage for nucleotide excision repair (NER), in which a damaged stretch of DNA was snipped out and replaced by an accurate copy.

V-01 as a Sequential Booster Can Produce Good Protection against Omicron ---- Latest Phase III Data of COVID-19 Vaccine by Livzon Pharma

Retrieved on: 
Friday, February 18, 2022
World Health Organization response to the COVID-19 pandemic in Africa, Emergency Use Authorization, Chinese Academy of Sciences, EUA, Incidence, Phase, Immunization, Death, Azkals Development Team, The Institute, Safety, Institute of Biophysics, Chinese Academy of Sciences, Omicron, Institute, WHO, Running, Research, COVID-19, Beta, V-01, Pharmaceutical industry, Vaccine, Biophysics, Delta

Although COVID-19 vaccine booster shots have been administered across the globe since 3Q2021, vaccine efficacy is shown to vary among vaccine products, and it is crucial to find and apply a vaccine with stronger protection against Omicron.

Key Points: 
  • Although COVID-19 vaccine booster shots have been administered across the globe since 3Q2021, vaccine efficacy is shown to vary among vaccine products, and it is crucial to find and apply a vaccine with stronger protection against Omicron.
  • Livzon Pharmaceutical Group Inc. ("Livzon"), a long-established pharmaceutical company dedicated to research and development of innovative product, has developed a recombinant protein COVID-19 vaccine (the "V-01 vaccine") leveraging their recombinant protein technology platform since 2021.
  • On February 16, Livzon has completed the interim analysis of the Phase III clinical trial for the sequential booster protocol, and released key data from this trial.
  • This is the first COVID-19 vaccine in the world of which the Phase III trial interim results have been disclosed since the Omicron outbreak.

QIAGEN’s New Generation of QuantiFERON TB Test Gains Chinese Approval and Renewed WHO Recommendation

Retrieved on: 
Monday, February 7, 2022
Research, Medical Supplies, Infectious Diseases, Hospitals, Clinical Trials, Biotechnology, General Health, Pharmaceutical, Health, Science, Policy, Chinese Academy of Medical Sciences COVID-19 vaccine, Knowledge, LTBI, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Senior, RNA, QFT, Automation, Growth, GDF, QIAGEN, Protein, Research, Solution, HIV, Infection, Molecular diagnostics, Interferon gamma release assay, Technology, Budget, U.S. Securities and Exchange Commission, Global, Diagnosis, Institute, Blood, UNITAID, SEC, Method, DNA, Life, Stop TB Partnership, Institute of Biophysics, Chinese Academy of Sciences, Central business district, QuantiFERON, NMPA, IGRA, Non-functional testing, Disease, Diabetes, Immunodeficiency, National Medical Products Administration, WHO, Medicine, Tuberculosis, TST, Pharmaceutical industry, Vaccine, Insight, TB, Academy, Pharma

Since 2013, more than 1.5 million people in China have been tested for active TB infection using the proprietary QuantiFERON technology.

Key Points: 
  • Since 2013, more than 1.5 million people in China have been tested for active TB infection using the proprietary QuantiFERON technology.
  • The WHO has renewed its recommendation that blood-based Interferon-Gamma Release Assays (IGRA) are an alternative for the diagnosis of TB infection, in addition to the Tuberculin Skin Test (TST).
  • QIAreach QFT was launched in late 2021 and was recently approved by the Global Funds Expert Review Panel Diagnostics (ERPD).
  • "The world needs new technologies and methods to contest TB and QIAGENs IGRA technology is playing a crucial role here.

Malnutrition in Early Life Sets Stage for Metabolic Disorders, Says New Review in Chinese Medical Journal

Retrieved on: 
Monday, January 24, 2022
Patient, Peking Union Medical College, Chinese Academy of Medical Sciences COVID-19 vaccine, Incidence, Metabolic disorder, Respiration (physiology), Infant, Adult, DNA, Review, Pandemic, Lists of diseases, Chinese Medical Journal, Institute of Biophysics, Chinese Academy of Sciences, Fetus, YouTube, Pregnancy, Risk, Medicine, Metabolism, DNA methylation, Life, Conditional sentence, Mirna, Awareness, Pharmaceutical industry, Medical device

The general consensus is the onset of metabolic disorders in adult life depends mostly on genetic predisposition and lifestyle.

Key Points: 
  • The general consensus is the onset of metabolic disorders in adult life depends mostly on genetic predisposition and lifestyle.
  • Clinical studies show that inappropriate nutrition during pregnancy and early life can set the stage for metabolic disorders in adulthood.
  • This happens because the fetus or newborn performs a preventive metabolic programming to 'prepare' itself for later in life.
  • Title of original paper: Early-life nutrition and metabolic disorders in later life: a new perspective on energy metabolism